FDA: Some EpiPens recalled
April 03, 2017
The manufacturer of EpiPen and EpiPen Jr is voluntarily recalling 13 lots of the device used to treat severe allergic reactions because they may contain a defective part, the U.S. Food and Drug Administration said March 31.
The lots of the device, distributed between Dec. 17, 2015 and July 1, 2016, may contain a part that could result in the devices' failure to activate, the FDA said in a news release, though the number of reported failures is small. The product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.
The FDA said consumers should keep and use their current EpiPens if needed until they get a replacement. Consumers who have EpiPens from lots not included in the recall do not need to replace their EpiPens prior to the expiration date.
To see which lots were recalled, click here
Health care professionals and consumers can report
adverse events or quality problems experienced with the use of these tablets and gels online at www.FDA.gov
and searching for "MedWatch."
Dentists can look for shortage notices, safety alerts and product recalls on the ADA Safety Alerts website
by visiting ADA.org/SafetyAlerts